Clinical Trial Update: Comparative Efficacy and Safety of Thalidomide and Sulfasalazine in Moderate to Severe Ankylosing Spondylitis: A Real-World Study From Bangladesh [Phase 3]

View source ↗

Summary

This document notes the completion of a Phase 3 real-world study from Bangladesh comparing thalidomide and sulfasalazine for moderate-to-severe ankylosing spond…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Axial Spondyloarthritis

Drugs mentioned

• Azulfidine (sulfasalazine)
• Thalomid (thalidomide)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Comparative Efficacy and Safety of Thalidomide and Sulfasalazine in Moderate to Severe Ankylosing Spondylitis: A Real-World Study From Bangladesh, Condition ...Moderate to Severe Axial Spondyloarthopathy | Phase 3 | Status: COMPLETED